Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9VMQ7

Entry ID Method Resolution Chain Position Source
AF-Q9VMQ7-F1 Predicted AlphaFoldDB

No variants for Q9VMQ7

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q9VMQ7

No associated diseases with Q9VMQ7

No regional properties for Q9VMQ7

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q9VMQ7

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
elongator holoenzyme complex A heterohexameric protein complex composed two discrete heterotrimeric subcomplexes that is involved in modification of wobble nucleosides in tRNA.
transcription elongation factor complex Any protein complex that interacts with RNA polymerase II to increase (positive transcription elongation factor) or reduce (negative transcription elongation factor) the rate of transcription elongation.

1 GO annotations of molecular function

Name Definition
phosphorylase kinase regulator activity Modulation of the activity of the enzyme phosphorylase kinase.

2 GO annotations of biological process

Name Definition
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
tRNA wobble uridine modification The process in which a uridine in position 34 of a tRNA is post-transcriptionally modified.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MTSFRKRTVQ KPIRGTRTSP HTAQVITSSG NPYLDVVIGG GLPMGSICLI EEDRFMTHAK
70 80 90 100 110 120
VLAKYFLAEG VISKQEIFLG SLDDIPAEML RRLPRPLTDQ ESMEQSEVQA LGDAGAENGL
130 140 150 160 170 180
RIAWRYNDLP LVNSEHATAK IGHHFNLMEQ MDSMMLYNVK TTLWDDSPKH LDIVIDEEFS
190 200 210 220 230 240
KSSSPTTPSL EQQPVEDAPP IPGTETAPQE KMPAQEEENS ANNNNNNNNN SSSVTSSTKT
250 260 270 280 290 300
GSQDSPLQVF HNPRYKGLLN DIQQLLRNES FVAGTKNNLC RVCLTSLGSP LWYDEHFGED
310 320 330 340 350 360
LIKFLTLLMA SVRNCNSVCL ITMPMHLIAK YDASLVPKIR QLVDYAIELE SFAGSERETH
370 380 390 400 410 420
PAFKEYSGLL HLHKMSAINT LAVHMPETPD LAFKLRRKKF IIEKFHLPPE LQESSAKPDN
430
CISGLLSNSN ATASLDF